About BioStem Technologies

Since our founding in 2014, we’ve pursued a singular goal: growing into an innovative life sciences company with the power to change lives for the better. BioStem Technologies is a leading manufacturer and distributor of superior perinatal tissue products for use in regenerative therapies. Our team has extensive scientific, medical and technical expertise in birth tissue processing for biologic products.
Over 5,000 procedures have been conducted using BioStem products, with zero reported adverse events.  Through our rigorous quality and proprietary production processes, we demonstrate our commitment to excellence and our focus on patient safety.
Learn About Our Products

Core Values

Quality

We exceed the highest quality standards, ensuring our products more than meet industry standard specifications.

Compassion

Our motto, "Science With Humanity" is more than just a clever saying, it's how we govern our practices.

Innovation

By developing novel approaches to industry changing processes, we focus on better than status quo.

What is Regenerative Medicine?

Soft tissue damage through disease and injury has catapulted the development of specialized therapies that can regenerate these tissues and decrease the reliance on limited steroidal treatments or addictive opioid prescriptions for pain. Regenerative medicine, on the whole, is an interdisciplinary field that applies engineering and life science principles to promote this regeneration with the hope of restoring the diseased or injured tissues.
Get More Information

Using Perinatal Tissue In Regenerative Therapies

The first reported clinical use of perinatal-derived tissue allografts for aiding in wound healing was at Johns Hopkins over a century ago in 1910. In recent years, both clinical and research applications of these biomaterials have increased in scope to include roles in tissue engineering and regenerative medicine. Perinatal tissues are an abundant source of extracellular matrix components and growth factors, with potential use in a broad array of regenerative therapies. These components have translated well to regenerative applications owing to their low immunogenicity, positive wound healing characteristics, and minimal tissue inflammation1-2. The two most widely adopted perinatal components for clinical use are the umbilical cord and the amniotic membrane.
Learn About Perinatal Tissue Components

Subscribe To Our Newsletter

To stay up to date on all of our news, products, and achievements, please subscribe to our newsletter

Contact Information

info@biostemtech.com
(954) 380-8342

Location

2836 Center Port Circle
Pompano Beach, FL 33064

Social

Links

Investors

Terms of Use

Privacy Policy

Shipping Policy

Refund Policy

© 2020 BioStem Technologies. All Rights Reserved. Use of this site is subject to certain Terms Of Use and Privacy Policy.
For screen reader problems with this website, please call (954) 380-8342 for assistance.

References
1. Fukuchi, Y., Nakajima, H., Sugiyama, D., Hirose, I., Kitamura, T. and Tsuji, K. (2004), Human Placenta‐Derived Cells Have Mesenchymal Stem/Progenitor Cell Potential. STEM CELLS, 22: 649-658. doi:10.1634/stemcells.22-5-649
2. W.Page Faulk, PeterJ Stevens, Hugo Burgos, Richard Matthews, JohnP Bennett, Bae-Li Hsi, HUMAN AMNION AS AN ADJUNCT IN WOUND HEALING, The Lancet, Volume 315, Issue 8179,1980, Pages 1156-1158, ISSN 0140-6736, https://doi.org/10.1016/S0140-6736(80)91617-7